These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14756543)

  • 1. TP53 codon 72 polymorphism does not affect risk of cervical cancer in patients from The Gambia.
    Tanara G; Falugi C; Cesario A; Margaritora S; Russo P; Cosimi A
    Int J Biol Markers; 2003; 18(4):280-3. PubMed ID: 14756543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 polymorphism, HPV infection, and risk of cervical cancer.
    Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women.
    Arbel-Alon S; Menczer J; Feldman N; Glezerman M; Yeremin L; Friedman E
    Int J Gynecol Cancer; 2002; 12(6):741-4. PubMed ID: 12445252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.
    Zehbe I; Voglino G; Wilander E; Delius H; Marongiu A; Edler L; Klimek F; Andersson S; Tommasino M
    Cancer Res; 2001 Jan; 61(2):608-11. PubMed ID: 11212257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India.
    Pillai MR; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):627-31. PubMed ID: 12458344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women.
    Pegoraro RJ; Rom L; Lanning PA; Moodley M; Naiker S; Moodley J
    Int J Gynecol Cancer; 2002; 12(4):383-8. PubMed ID: 12144687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
    Alsbeih GA; Al-Harbi NM; Bin Judia SS; Khoja HA; Shoukri MM; Tulbah AM
    Cancer; 2017 Jul; 123(13):2459-2466. PubMed ID: 28393355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 codon 72 polymorphism and its association with bladder cancer.
    Soulitzis N; Sourvinos G; Dokianakis DN; Spandidos DA
    Cancer Lett; 2002 May; 179(2):175-83. PubMed ID: 11888672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk.
    Inserra P; Abrahamsen M; Papenfuss M; Giuliano AR
    Int J STD AIDS; 2003 Dec; 14(12):800-4. PubMed ID: 14678586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
    Li CY; Liu JH; Huang BJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy.
    Tenti P; Vesentini N; Rondo Spaudo M; Zappatore R; Migliora P; Carnevali L; Ranzani GN
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):435-8. PubMed ID: 10794489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women.
    Bhattacharya P; Duttagupta C; Sengupta S
    Cancer Lett; 2002 Dec; 188(1-2):207-11. PubMed ID: 12406566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.
    El khair MM; Ennaji MM; El kebbaj R; Mhand RA; Attaleb M; El Mzibri M
    Med Oncol; 2010 Sep; 27(3):861-6. PubMed ID: 19771536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
    Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
    Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions.
    Min-min H; Ming-rong X; Ze-yi C; Kai-xuan Y; Zhi-lin S
    Int J Gynecol Cancer; 2006; 16(6):2004-8. PubMed ID: 17177838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation.
    Makni H; Franco EL; Kaiano J; Villa LL; Labrecque S; Dudley R; Storey A; Matlashewski G
    Int J Cancer; 2000 Aug; 87(4):528-33. PubMed ID: 10918193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism.
    Tachezy R; Mikysková I; Saláková M; Van Ranst M
    Hum Genet; 1999 Dec; 105(6):564-6. PubMed ID: 10647890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.
    Piña-Sánchez P; Hernández-Hernández DM; Taja-Chayeb L; Cerda-Flores RM; González-Herrera AL; Rodea-Avila C; Apresa-García T; Ostrosky-Wegman P; Vázquez-Ortíz G; Mendoza-Lorenzo P; Dueñas-González A; Salcedo M
    Med Oncol; 2011 Dec; 28(4):1507-13. PubMed ID: 20661667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study.
    Apu MNH; Rashed AZM; Bashar T; Rahman MM; Mostaid MS
    Mol Biol Rep; 2020 Jun; 47(6):4357-4364. PubMed ID: 32424519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between p53 codon-72 polymorphism and squamous intraepithelial lesions in women with, or at risk for, human immunodeficiency virus and/or human papillomavirus infections.
    Rezza G; Giuliani M; Garbuglia AR; Serraino D; Cappiello G; Migliore G; Branca M; Benedetto A; Ippolito G
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):565-6. PubMed ID: 11352871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.